CUSIP 92764N102COMVIRQ4 2025
31 filings · latest Mar 3, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 16.33M | $98.47M |
| 2 | Sb Investment Advisers (Uk) Ltd | 13.12M | $79.10M |
| 3 | Arch Venture Management, LLC | 12.92M | $77.89M |
| 4 | Vanguard Group Inc | 12.55M | $75.67M |
| 5 | Gsk PLC | 8.55M | $51.56M |
| 6 | State Street Corp | 6.23M | $37.56M |
| 7 | Fmr LLC | 3.16M | $19.05M |
| 8 | Morgan Stanley | 2.68M | $16.16M |
| 9 | Dimensional Fund Advisors LP |
| 4 | Oct 18, 2024 | State Street Corp | 13G/A | 4.1% | 5.63M | SEC |
| 5 | Feb 13, 2024 | Sb Investment Advisers (Uk) Ltd | 13G/A | 12.4% | 16.68M | SEC |
| 6 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 9.1% | 12.30M | SEC |
| 7 | Jan 24, 2024 | State Street Corp | 13G | 5.1% | — | SEC |
| 8 | Jan 23, 2024 | Blackrock Inc. | 13G/A | 12.5% | 16.86M | SEC |
| 9 | Feb 14, 2023 | Softbank Vision Fund (Aiv M1) L.P. | 13G/A | 15.2% | 20.26M | SEC |
| 10 | Feb 9, 2023 | Vanguard Group Inc | 13G/A | 7.6% | 10.09M | SEC |
See the full Schedule 13D/13G history for Vir Biotechnology Inc.
Unlock full history| 2.54M |
| $15.29M |
| 10 | Orbimed Advisors LLC | 2.38M | $14.36M |